vs
Side-by-side financial comparison of ON Semiconductor (ON) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
ON Semiconductor is the larger business by last-quarter revenue ($1.6B vs $1.1B, roughly 1.4× PERRIGO Co plc). ON Semiconductor runs the higher net margin — 16.4% vs -127.8%, a 144.2% gap on every dollar of revenue. On growth, PERRIGO Co plc posted the faster year-over-year revenue change (-2.5% vs -10.0%). ON Semiconductor produced more free cash flow last quarter ($372.4M vs $148.6M). Over the past eight quarters, PERRIGO Co plc's revenue compounded faster (1.3% CAGR vs -12.3%).
Fairchild Semiconductor International, Inc. was an American semiconductor company based in San Jose, California. It was founded in 1957 as a division of Fairchild Camera and Instrument by the "traitorous eight" who defected from Shockley Semiconductor Laboratory. It became a pioneer in the manufacturing of transistors and of integrated circuits. Schlumberger bought the firm in 1979 and sold it to National Semiconductor in 1987; Fairchild was spun off as an independent company again in 1997. I...
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
ON vs PRGO — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.6B | $1.1B |
| Net Profit | $255.0M | $-1.4B |
| Gross Margin | 37.9% | 32.6% |
| Operating Margin | 17.0% | -116.0% |
| Net Margin | 16.4% | -127.8% |
| Revenue YoY | -10.0% | -2.5% |
| Net Profit YoY | -32.9% | -3093.9% |
| EPS (diluted) | $0.63 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.6B | $1.1B | ||
| Q3 25 | $1.5B | $1.0B | ||
| Q2 25 | $1.4B | $1.1B | ||
| Q1 25 | — | $1.0B | ||
| Q4 24 | $1.7B | $1.1B | ||
| Q3 24 | $1.8B | $1.1B | ||
| Q2 24 | $1.7B | $1.1B | ||
| Q1 24 | $1.9B | $1.1B |
| Q4 25 | $255.0M | $-1.4B | ||
| Q3 25 | $170.3M | $7.5M | ||
| Q2 25 | $-486.1M | $-8.4M | ||
| Q1 25 | — | $-6.4M | ||
| Q4 24 | $379.9M | $-44.4M | ||
| Q3 24 | $401.7M | $-21.0M | ||
| Q2 24 | $338.2M | $-108.4M | ||
| Q1 24 | $453.0M | $2.0M |
| Q4 25 | 37.9% | 32.6% | ||
| Q3 25 | 37.6% | 36.1% | ||
| Q2 25 | 20.3% | 34.4% | ||
| Q1 25 | — | 37.6% | ||
| Q4 24 | 45.2% | 33.9% | ||
| Q3 24 | 45.4% | 37.2% | ||
| Q2 24 | 45.2% | 37.0% | ||
| Q1 24 | 45.8% | 33.1% |
| Q4 25 | 17.0% | -116.0% | ||
| Q3 25 | 13.2% | 7.0% | ||
| Q2 25 | -39.7% | 4.3% | ||
| Q1 25 | — | 4.5% | ||
| Q4 24 | 23.7% | 10.0% | ||
| Q3 24 | 25.3% | 7.4% | ||
| Q2 24 | 22.4% | -2.5% | ||
| Q1 24 | 28.2% | -5.1% |
| Q4 25 | 16.4% | -127.8% | ||
| Q3 25 | 11.6% | 0.7% | ||
| Q2 25 | -33.6% | -0.8% | ||
| Q1 25 | — | -0.6% | ||
| Q4 24 | 22.1% | -3.9% | ||
| Q3 24 | 22.8% | -1.9% | ||
| Q2 24 | 19.5% | -10.2% | ||
| Q1 24 | 24.3% | 0.2% |
| Q4 25 | $0.63 | $-10.23 | ||
| Q3 25 | $0.41 | $0.05 | ||
| Q2 25 | $-1.15 | $-0.06 | ||
| Q1 25 | — | $-0.05 | ||
| Q4 24 | $0.88 | $-0.32 | ||
| Q3 24 | $0.93 | $-0.15 | ||
| Q2 24 | $0.78 | $-0.79 | ||
| Q1 24 | $1.04 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.9B | — |
| Total DebtLower is stronger | $3.4B | — |
| Stockholders' EquityBook value | $7.9B | $2.9B |
| Total Assets | $13.0B | $8.5B |
| Debt / EquityLower = less leverage | 0.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.9B | — | ||
| Q3 25 | $2.8B | $432.1M | ||
| Q2 25 | $3.0B | $454.2M | ||
| Q1 25 | — | $409.9M | ||
| Q4 24 | $3.0B | $558.8M | ||
| Q3 24 | $2.8B | $1.5B | ||
| Q2 24 | $2.7B | $542.8M | ||
| Q1 24 | $2.6B | $658.5M |
| Q4 25 | $3.4B | — | ||
| Q3 25 | $3.4B | — | ||
| Q2 25 | $3.4B | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $3.4B | — | ||
| Q3 24 | $3.4B | — | ||
| Q2 24 | $3.4B | — | ||
| Q1 24 | $3.4B | — |
| Q4 25 | $7.9B | $2.9B | ||
| Q3 25 | $7.9B | $4.4B | ||
| Q2 25 | $8.0B | $4.5B | ||
| Q1 25 | — | $4.4B | ||
| Q4 24 | $8.8B | $4.3B | ||
| Q3 24 | $8.6B | $4.6B | ||
| Q2 24 | $8.3B | $4.5B | ||
| Q1 24 | $8.1B | $4.7B |
| Q4 25 | $13.0B | $8.5B | ||
| Q3 25 | $13.1B | $10.1B | ||
| Q2 25 | $13.3B | $10.1B | ||
| Q1 25 | — | $9.8B | ||
| Q4 24 | $14.1B | $9.6B | ||
| Q3 24 | $13.9B | $11.2B | ||
| Q2 24 | $13.7B | $10.4B | ||
| Q1 24 | $13.5B | $10.6B |
| Q4 25 | 0.43× | — | ||
| Q3 25 | 0.43× | — | ||
| Q2 25 | 0.42× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.38× | — | ||
| Q3 24 | 0.39× | — | ||
| Q2 24 | 0.41× | — | ||
| Q1 24 | 0.42× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $418.7M | $175.4M |
| Free Cash FlowOCF − Capex | $372.4M | $148.6M |
| FCF MarginFCF / Revenue | 24.0% | 13.4% |
| Capex IntensityCapex / Revenue | 3.0% | 2.4% |
| Cash ConversionOCF / Net Profit | 1.64× | — |
| TTM Free Cash FlowTrailing 4 quarters | $1.4B | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $418.7M | $175.4M | ||
| Q3 25 | $184.3M | $51.7M | ||
| Q2 25 | $602.3M | $75.9M | ||
| Q1 25 | — | $-64.5M | ||
| Q4 24 | $579.7M | $312.6M | ||
| Q3 24 | $465.8M | $42.2M | ||
| Q2 24 | $362.2M | $9.5M | ||
| Q1 24 | $498.7M | $-1.4M |
| Q4 25 | $372.4M | $148.6M | ||
| Q3 25 | $106.1M | $29.8M | ||
| Q2 25 | $454.7M | $56.7M | ||
| Q1 25 | — | $-90.0M | ||
| Q4 24 | $434.8M | $274.9M | ||
| Q3 24 | $293.6M | $15.1M | ||
| Q2 24 | $207.7M | $-18.9M | ||
| Q1 24 | $276.3M | $-26.5M |
| Q4 25 | 24.0% | 13.4% | ||
| Q3 25 | 7.2% | 2.9% | ||
| Q2 25 | 31.5% | 5.4% | ||
| Q1 25 | — | -8.6% | ||
| Q4 24 | 25.2% | 24.2% | ||
| Q3 24 | 16.7% | 1.4% | ||
| Q2 24 | 12.0% | -1.8% | ||
| Q1 24 | 14.8% | -2.4% |
| Q4 25 | 3.0% | 2.4% | ||
| Q3 25 | 5.3% | 2.1% | ||
| Q2 25 | 10.2% | 1.8% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | 8.4% | 3.3% | ||
| Q3 24 | 9.8% | 2.5% | ||
| Q2 24 | 8.9% | 2.7% | ||
| Q1 24 | 11.9% | 2.3% |
| Q4 25 | 1.64× | — | ||
| Q3 25 | 1.08× | 6.89× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.53× | — | ||
| Q3 24 | 1.16× | — | ||
| Q2 24 | 1.07× | — | ||
| Q1 24 | 1.10× | -0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ON
| Industrial Segment | $426.3M | 27% |
| Other End Markets Segment | $337.3M | 22% |
| Intelligent Sensing Segments | $284.0M | 18% |
| Direct Customers | $282.4M | 18% |
| Intelligent Sensing Group | $230.0M | 15% |
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
